Research programme: metabolic disorder therapeutics - Curl Bio
Latest Information Update: 11 Aug 2016
At a glance
- Originator Curl Bio
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Metabolic syndrome; Obesity; Type 2 diabetes mellitus
Most Recent Events
- 11 Aug 2016 Early research in Type-2 diabetes mellitus in USA (unspecified route)
- 11 Aug 2016 Early research in Obesity in USA (unspecified route)
- 11 Aug 2016 Early research in Metabolic syndrome in USA (unspecified route)